Bank Analysts Downgrades These Healthcare Stocks in December: MDT, JAZZ, PCYC

Wall St. Watchdog reveals information about companies for which stock analysts downgraded shares in the Healthcare sector for the week ending December 9th, 2011.

  • Medtronic (NYSE:MDT): Standpoint Research downgraded its rating on this company from Buy to Hold on Dec 5th. The shares recently traded at $35.45, down $0.53, or 1.47% since the analyst’s rating. About the company: Medtronic, Inc. develops therapeutic and diagnostic medical products. The Company’s principal products include those for bradycardia pacing, tachyarrhythmia management, atrial fibrillation management, heart failure management, heart valve replacement, malignant and non-malignant pain, and movement disorders. Medtronic’s products are sold worldwide. Get the most recent company news and stock data here >>
  • Jazz Pharma (NASDAQ:JAZZ): WBB Securities downgraded its rating on this company from Buy to Hold and changed its price target from $15 to $40 on Dec 8th. The shares recently traded at $35.63, down $1.01, or 2.76% since the analyst’s rating. About the company: Jazz Pharmaceuticals, Inc. develops and markets treatments for neurological and psychiatric conditions. The Company produces treatments for cataplexy, excessive daytime sleepiness, and ethylene glycol and methanol poisoning in humans. Get the most recent company news and stock data here >>
  • Pharmacyclics (NASDAQ:PCYC): Global Hunter Securities downgraded its rating on this company from Buy to Neutral and changed its price target to $15 on Dec 9th. The shares recently traded at $12.65, up $0.26, or 2.1% since the analyst’s rating. About the company: Pharmacyclics, Inc. is a pharmaceutical company developing products to improve upon current therapeutic approaches to cancer, atherosclerosis, and retinal disease. The Company’s products are patented agents derived from its technology platform for designing and synthesizing energy-potentiating drugs. Get the most recent company news and stock data here >>

(Note: Selected financial data are sourced from Briefing.com via the Wall St. Journal. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>